ZYNERBA PHARMACEUTICALS, INC. Shareholders' Equity
ZYNERBA PHARMACEUTICALS, INC. had Shareholders' Equity of $29.02 million as of 2023-06-30, per its 10-Q filed 2023-08-14.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2023-08-14
- 2023-06-30: Stockholders' Equity Attributable to Parent $29.02M.
- 2023-03-31: Stockholders' Equity Attributable to Parent $38.97M.
- 2022-12-31: Stockholders' Equity Attributable to Parent $46.23M.
- 2022-09-30: Stockholders' Equity Attributable to Parent $52.76M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2023-06-30 | $29.02M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $38.97M 10-Q · filed 2023-08-14 |
| 2022-12-31 | $46.23M 10-Q · filed 2023-08-14 |
| 2022-09-30 | $52.76M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $57.24M 10-Q · filed 2023-08-14 |
| 2022-03-31 | $65.17M 10-Q · filed 2023-08-14 |
| 2021-12-31 | $70.91M 10-Q · filed 2023-08-14 |
| 2021-09-30 | $78.69M 10-Q · filed 2022-11-14 |
| 2021-06-30 | $87.70M 10-Q · filed 2022-11-14 |
| 2021-03-31 | $95.71M 10-Q · filed 2022-11-14 |
| 2020-12-31 | $60.14M 10-K · filed 2023-03-28 |
| 2020-09-30 | $66.64M 10-Q · filed 2021-11-15 |
| 2020-06-30 | $74.43M 10-Q · filed 2021-11-15 |
| 2020-03-31 | $66.16M 10-Q · filed 2021-11-15 |
| 2019-12-31 | $75.60M 10-K · filed 2023-03-28 |
| 2019-09-30 | $85.01M 10-Q · filed 2020-11-09 |
| 2019-06-30 | $85.58M 10-Q · filed 2020-11-09 |
| 2019-03-31 | $68.03M 10-Q · filed 2020-11-09 |
| 2018-12-31 | $57.60M 10-K · filed 2022-03-01 |
| 2018-09-30 | $63.79M 10-Q · filed 2019-11-06 |
| 2018-06-30 | $40.08M 10-Q · filed 2019-11-06 |
| 2018-03-31 | $50.33M 10-Q · filed 2019-11-06 |
| 2017-12-31 | $60.95M 10-K · filed 2021-03-10 |
| 2017-09-30 | $64.64M 10-Q · filed 2017-11-14 |
| 2017-06-30 | $71.23M 10-Q · filed 2017-08-01 |
| 2017-03-31 | $77.76M 10-Q · filed 2017-05-09 |
| 2016-12-31 | $29.59M 10-K · filed 2020-03-10 |
| 2016-09-30 | $30.88M 10-Q · filed 2016-11-14 |
| 2016-06-30 | $30.77M 10-Q · filed 2016-08-11 |
| 2016-03-31 | $36.19M 10-Q · filed 2016-05-12 |
| 2015-12-31 | $39.71M 10-K · filed 2019-03-11 |
| 2015-09-30 | $44.38M 10-Q · filed 2015-11-12 |
| 2015-06-30 | -$11.17M 10-Q · filed 2015-08-27 |
| 2014-12-31 | -$8.05M 10-K · filed 2018-03-12 |
| 2013-12-31 | -$4.36M 10-K · filed 2017-03-27 |
| 2012-12-31 | -$3.56M 10-K · filed 2016-03-14 |